PSA announces 2026 Faye McMillan Conference Grant recipients
27 May 2026
The Pharmaceutical Society of Australia (PSA) has marked the beginning of National Reconciliation Week by announcing the recipients of the 2026 PSA Faye McMillan Conference Grant.
Returning for the fourth consecutive year, the PSA Faye McMillan Conference Grant supports Aboriginal and or Torres Strait Islander pharmacists, interns, and or pharmacy students to attend PSA’s national annual conference.
Professor Faye McMillan AM FPS is a Wiradjuri yinaa (Wiradjuri woman) originally from Trangie, NSW, and is recognised as the first Indigenous Australian to hold a Western degree in pharmacy.
The PSA has committed to supporting the workforce participation of First Nations Australians across the pharmacy profession and is proud to honour Professor Faye McMillan AM FPS in this way.
Sponsored this year by Camurus, alongside Care Pharmaceuticals and Hydralyte, the PSA are pleased to announce the recipients of the 2026 PSA Faye McMillan Conference Grant are:
- Eliza Brown
- Caleb Foster
- Penny May
PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest Chair, Ms Chastina Heck MPS, said the return of the PSA Faye McMillan Conference Grant supports PSA’s commitment to empowering the next generation of First Nations pharmacists.
“This empowerment starts with creating a sense of belonging within the pharmacy profession and is an essential early step in growing our First Nations workforce,” she said.
“The legacy of the Faye McMillan grant reflects the importance of facilitating relationships based on authenticity and creating that welcoming environment.”
A spokesperson for Camurus Pty Ltd said:
“Camurus is proud to support the PSA Faye McMillan Conference Grant and help strengthen opportunities for First Nations pharmacists.
“Supporting Indigenous leadership and representation in healthcare is essential to improving outcomes for communities across Australia.
“We wish the recipients and the PSA a successful PSA2026 conference.”
A spokesperson for Care Pharmaceuticals and Hydralyte said:
“Care Pharmaceuticals is proud to continue supporting the PSA Faye McMillan Conference Grant, which recognises the outstanding contributions of Indigenous pharmacists, including Professor Faye McMillan, in advancing equitable healthcare for Aboriginal and Torres Strait Islander communities.
“Through this partnership, Care Pharmaceuticals and Hydralyte reaffirm our commitment to fostering diversity and inclusion within the pharmacy profession and supporting culturally safe healthcare for all Australians.
“Now in our third year of supporting this important initiative, we are delighted to continue our partnership with PSA and remain committed to contributing to the ongoing success of the program.”
More information about the 2026 PSA Faye McMillan Conference Grant is available here: https://www.psa.org.au/the-psa-faye-mcmillan-conference-grant-returns-for-a-fourth-consecutive-year/.
Media contact: Leah Jacobsen
M: 0480 099 798 E: leah.jacobsen@psa.org.au
The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.
